QUANTUM GENOMICS

Pharmaceutical combination comprising a brain aminopeptidase a inhibitor, a diuretic and a blocker of the systemic renin-angiotensin system

N° IL297587A

PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM

N° ZA202211302B

ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΡΙΥΔΡΙΤΗ TOY (3S,3S') 4,4'-ΔΙΣΟΥΛΦΑΝΟΔΙΥΛΟΔΙΣ(3-ΑΜΙΝΟΒΟΥΤΑΝΟ 1-ΣΟΥΛΦΟΝΙΚΟΥ ΟΞΕΟΣ)

N° CY1124919T1

COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR TREATING HYPERTENSION OR HEART FAILURE

N° ZA202107513B

Compounds and compositions comprising the same for treating hypertension or heart failure

N° IL285593A

NOVEL AMINOPHOSPHINIC DERIVATIVES AS AMINOPEPTIDASE A INHIBITORS

N° ZA202103581B

AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

N° ZA202103580B

COMBINACIÓN FARMACÉUTICA QUE COMPRENDE UN INHIBIDOR DE AMINOPEPTIDASA CEREBRAL A, UN DIURÉTICO Y UN BLOQUEADOR DEL SISTEMA DE RENINA-ANGIOTENSINA SISTÉMICO

N° AR122022A1

PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM

N° EP4146199A1

PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM

N° CA3176024A1

PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM.

N° MX2022013929A

PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM

N° WO2021224354A1

COMBINAÇÃO FARMACÊUTICA COMPREENDENDO UM INIBIDOR DA AMINOPEPTIDASE CEREBRAL A, UM DIURÉTICO E UM BLOQUEADOR DO SISTEMA RENINA-ANGIOTENSINA SISTÊMICO

N° BR112022022368A2

뇌 아미노펩티다제 A 억제제, 이뇨제, 및 전신 레닌-안지오텐신 시스템의 차단제를 포함하는 약학 병용물

N° KR20230006884A

Pharmaceutical combination comprising a brain aminopeptidase A inhibitor, a diuretic and a blocker of the systemic renin-angiotensin system

N° AU2021267695A1

PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM

N° US2023233492A1

Pharmaceutical combination comprising brain aminopeptidase inhibitor, diuretic and systemic renin-angiotensin system blocker

N° CN115605199A

AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

N° MX2021004741A

Aminopeptidase a inhibitors and pharmaceutical compositions comprising the same

N° IL282591A

Pharmaceutical combination comprising a brain aminopeptidase inhibitor, a diuretic and a blocker of the systemic renin-angiotensin system

N° TW202207917A

Novel aminophosphinic derivatives as aminopeptidase a inhibitors

N° IL282484A

COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR TREATING HYPERTENSION OR HEART FAILURE

N° EP3937924A1

Compuestos y composiciones que comprenden los mismos para el tratamiento de la hipertensión o falla cardíaca

N° ES2965293T3

COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR TREATING HYPERTENSION OR HEART FAILURE

N° CN113784710A

COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR TREATING HYPERTENSION OR HEART FAILURE.

N° MX2021011041A

COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR TREATING HYPERTENSION OR HEART FAILURE

N° WO2020182870A1

Compounds and compositions comprising the same for treating hypertension or heart failure

N° AU2020235216A1

COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR TREATING HYPERTENSION OR HEART FAILURE

N° CA3129677A1

Compounds and compositions comprising the same for treating hypertension or heart failure

N° US2022041548A1

Composto e composição farmacêutica compreendendo o mesmo

N° BR112021017158A2

COMPOSÉS ET COMPOSITIONS ASSOCIÉES POUR TRAITER UNE HYPERTENSION OU UNE INSUFFISANCE CARDIAQUE

N° MA55275A

COMPUESTOS DISULFURO Y COMPOSICIONES QUE COMPRENDEN LOS MISMOS PARA TRATAR HIPERTENSIÓN O FALLO CARDÍACO

N° AR118302A1

Compounds and composition comprising the same for treating hypertension or heart failure

N° TW202100146A

AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

N° EP3870591A1

Novel aminophosphinic derivatives as aminopeptidase A inhibitors

N° AU2019364708A1

NOVEL AMINOPHOSPHINIC DERIVATIVES AS AMINOPEPTIDASE A INHIBITORS.

N° MX2021004728A

AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

N° WO2020084131A1

NOVEL AMINOPHOSPHINIC DERIVATIVES AS AMINOPEPTIDASE A INHIBITORS

N° WO2020084147A1

NOVEL AMINOPHOSPHINIC DERIVATIVES AS AMINOPEPTIDASE A INHIBITORS

N° EP3870590A1

AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

N° CN113166182A

Novel aminophosphinic derivatives as aminopeptidase a inhibitors

N° TW202029965A

AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

N° CA3112851A1

INHIBIDORES DE AMINOPEPTIDASA A Y COMPOSICIONES FARMACÉUTICAS QUE COMPRENDEN LOS MISMOS

N° AR116853A1

inibidores de aminopeptidase a e composições farmacêuticas compreendendo os mesmos

N° BR112021007116A2

아미노펩티다아제 A 저해제로서의 신규의 아미노포스핀 유도체

N° KR20210090636A

NOVEL AMINOPHOSPHINIC DERIVATIVES AS AMINOPEPTIDASE A INHIBITORS

N° CN113166180A

AMINOPHOSPHINIC DERIVATIVES AS AMINOPEPTIDASE A INHIBITORS

N° CA3113391A1

Aminopeptidase a inhibitors and pharmaceutical compositions comprising the same

N° AU2019365119A1

DERIVADOS AMINOFOSFÍNICOS COMO INHIBIDORES DE AMINOPEPTIDASA A

N° AR116854A1

Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same

N° US2021309678A1

NOVEL AMINOPHOSPHINIC DERIVATIVES AS AMINOPEPTIDASE A INHIBITORS

N° US2021309677A1

composto e composição farmacêutica

N° BR112021007041A2

아미노펩티다아제 A 저해제 및 이것을 포함하는 약학 조성물

N° KR20210079336A

Aminopeptidase a inhibitors and pharmaceutical compositions comprising the same

N° TW202029962A

ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ TOY (3S,3S') 4,4'-ΔΙΣΟΥΛΦΑΝΟΔΙΥΛΟΔΙΣ (3-ΑΜΙΝΟΒΟΥΤΑΝΟ 1-ΣΟΥΛΦΟΝΙΚΟΥ ΟΞΕΟΣ)

N° CY1120859T1

ΚΡΥΣΤΑΛΛΙΚΗ ΦΑΣΗ (3S,3S΄)4,4΄-ΔΙΣΟΥΛΦΑΝΟΔΙΥΛΔΙΣ(3-ΑΜΙΝΟΒΟΥΤΑΝΟ 1-ΣΟΥΛΦΟΝΙΚΟΥ ΟΞΕΟΣ) ΜΕ L-ΛΥΣΙΝΗ

N° CY1119913T1

ΣΥΝΔΥΑΣΜΟΣ ( 3S, 3S' )4, 4'-ΔΙΣΟΥΛΦΑΝΟΔΙΥΛΟΔΙ (3-ΑΜΙΝΟΒΟΥΤΑΝΟ 1-ΣΟΥΛΦΟΝΙΚΟΥ ΟΞΕΟΣ) ΚΑΙ ΕΝΟΣ ΔΕΥΤΕΡΟΥ ΑΝΤΙΥΠΕΡΤΑΣΙΚΟΥ ΠΑΡΑΓΟΝΤΑ

N° CY1118711T1

Crystalline phase of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

N° US2016221940A1

CRYSTALLINE PHASE OF (3S.3S) 4,4-DISULFANEDIYLBIS(3-AMINOBUTANE 1 - SULFONIC ACID) WITH L-LYSINE (3S3S)-44-(3--1-) L-

N° HK1212321A1

Method for the preparation of (3S,3S′) 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid)

N° US2016046571A1

CRYSTALLINE PHASE OF (3S.3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1 -SULFONIC ACID) WITH L-LYSINE

N° ZA201503574B

COMBINATION OF (3S,3S) 4,4-DISULFANEDIYLBIS(3-AMINOBUTANE 1- SULFONIC ACID) AND A SECOND ANTIHYPERTENSIVE AGENT (3S3S)4,4-(3- 1-)

N° HK1203051A1

CRYSTALLINE PHASE OF (3S.3S ) 4 ,4' - DISULFANEDIYLBIS(3 -AMINOBUTANE 1- SULFONIC ACID) WITH L- LYSINE

N° IN2807DEN2015A

New crystalline phase of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) with l-lysine

N° IL237733B

COMBINATION OF (3S, 3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) AND A SECOND ANTIHYPERTENSIVE AGENT

N° ZA201405266B

COMBINATION OF (3S 3S ) 4 4 DISULFANEDIYLBIS(3 AMINOBUTANE 1 SULFONIC ACID) AND A SECOND ANTIHYPERTENSIVE AGENT

N° IN5787DEN2014A

Combination of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent

N° IL233156A0

33' 44'-3- 1- L- CRYSTALLINE PHASE OF 3S.3S' 44'-DISULFANEDIYLBIS3-AMINOBUTANE 1 -SULFONIC ACID WITH L-LYSINE

N° KR20150072454A

CRYSTALLINE PHASE OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE

N° EP2909169A1

New crystalline phase of (3s,3s')4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) with l-lysine

N° TW201418202A

CRYSTALLINE PHASE OF (3S.3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1 -SULFONIC ACID) WITH L-LYSINE

N° CA2884914A1

Crystalline phase of (3S.3S') 4,4'-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with L-lysine

N° AU2013336738A1

CRYSTALLINE PHASE OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE

N° SI2909169T1

CRYSTALLINE PHASE OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE

N° RS56896B1

CRYSTALLINE PHASE OF (3S,3S') 4,4'- DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE

N° ME02955B

Fase cristalina de (3S,3S') 4,4'-disulfanodiilbis(ácido 3-aminobutano 1-sulfónico) con L-lisina

N° ES2658413T3

Crystalline phase of (3s.3s’) 4,4’-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine

N° NZ706070A

CRYSTALLINE PHASE OF (3S.3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1 -SULFONIC ACID) WITH L-LYSINE

N° HRP20180189T1

CRYSTALLINE PHASE OF (3S.3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1 -SULFONIC ACID) WITH L-LYSINE

N° WO2014064077A1

CRYSTALLINE PHASE OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE

N° PT2909169T

forma cristalina de (3s,3s’) 4,4’-disulfanodiilbis(ácido 3-aminobutano 1-sulfônico) de absd; processo para a preparação de uma forma cristalina de absd e l-lisina; e composição farmacêutica

N° BR112015008931A2

CRYSTALLINE PHASE OF (3S,3S`) 4,4`-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE

N° LT2909169T

CRYSTALLINE FORM OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) COMPOUND WITH L-LYSINE

N° EA201500438A1

KRYSTALLINSK FASE AF (3S,3S') 4,4'-DISULFANDIYLBIS(3-AMINOBUTAN 1-SULFONSYRE) MED L-LYSIN

N° DK2909169T3

CRYSTALLINE PHASE OF (3S.3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1 -SULFONIC ACID) WITH L-LYSINE.

N° MX2015005059A

CRYSTALLINE PHASE OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE

N° HUE036037T2

CRYSTALLINE PHASE OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE

N° PL2909169T3

CRYSTALLINE PHASE OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE

N° SMT201800086T1

Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

N° US2015284325A1

FASE CRISTALINA DE (3S,3S) 4,4-DISULFANODIILBIS (ACIDO 3-AMINOBUTANO 1-SULFONICO) CON L-LISINA

N° AR093070A1

Method for the preparation of (3s,3s') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid)

N° IL225557A0

Combination of (3s, 3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent

N° CN104220062A

COMBINATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) AND A SECOND ANTIHYPERTENSIVE AGENT

N° PL2793878T3

Combination of (3S,3S') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent

N° AU2012356895A1

Combinación del ácido (3S,3S') 4,4'-disulfanodiilbis(3-aminobutano 1-sulfónico) y un segundo agente antihipertensivo

N° ES2619027T3

METHOD FOR TREATING ARTERIAL HYPERTENSION OR INDIRECTLY OR DIRECTLY RELATED DISEASES

N° EA201400724A1

COMBINATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) AND A SECOND ANTIHYPERTENSIVE AGENT

N° PT2793878T

combinação de (3s,3s’) 4,4’-dissulfanodiilbis(ácido 3-aminobutano 1-sulfônico) e um segundo agente anti-hipertensivo

N° BR112014015276A2

COMBINATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) AND A SECOND ANTIHYPERTENSIVE AGENT

N° EP2793878A1

COMBINATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) AND A SECOND ANTIHYPERTENSIVE AGENT

N° SMT201700156T1